+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Gastrointestinal Drugs Market Research Reports

Anal Fistula Epidemiology Forecast 2025-2034 - Product Thumbnail Image

Anal Fistula Epidemiology Forecast 2025-2034

  • Report
  • June 2025
  • 150 Pages
  • Global
From
Gastroparesis Epidemiology Forecast 2025-2034 - Product Thumbnail Image

Gastroparesis Epidemiology Forecast 2025-2034

  • Report
  • June 2025
  • 150 Pages
  • Global
From
Gastric Ulcers Epidemiology Forecast 2025-2034 - Product Thumbnail Image

Gastric Ulcers Epidemiology Forecast 2025-2034

  • Report
  • June 2025
  • 150 Pages
  • Global
From
Ulcerative Colitis (UC) Epidemiology Forecast 2025-2034 - Product Thumbnail Image

Ulcerative Colitis (UC) Epidemiology Forecast 2025-2034

  • Report
  • June 2025
  • 150 Pages
  • Global
From
Anal Fissure Epidemiology Forecast 2025-2034 - Product Thumbnail Image

Anal Fissure Epidemiology Forecast 2025-2034

  • Report
  • June 2025
  • 150 Pages
  • Global
From
Hemorrhoids Epidemiology Forecast 2025-2034 - Product Thumbnail Image

Hemorrhoids Epidemiology Forecast 2025-2034

  • Report
  • June 2025
  • 150 Pages
  • Global
From
From
From
From
Artificial Saliva Market Report and Forecast 2024-2032 - Product Thumbnail Image

Artificial Saliva Market Report and Forecast 2024-2032

  • Report
  • September 2024
  • 200 Pages
  • Global
From
Ursodeoxycholic Acid Market 2025-2029 - Product Thumbnail Image

Ursodeoxycholic Acid Market 2025-2029

  • Report
  • May 2025
  • 205 Pages
  • Global
From
Gastroparesis Drugs Market 2025-2029 - Product Thumbnail Image

Gastroparesis Drugs Market 2025-2029

  • Report
  • December 2024
  • 198 Pages
  • Global
From
From
From
Sorbitol - Global Strategic Business Report - Product Thumbnail Image

Sorbitol - Global Strategic Business Report

  • Report
  • July 2025
  • 246 Pages
  • Global
From
Hypoglycemia - Global Clinical Trials Review, 2025 - Product Thumbnail Image

Hypoglycemia - Global Clinical Trials Review, 2025

  • Clinical Trials
  • May 2025
  • 252 Pages
  • Global
From
Chemotherapy-Induced Diarrhea (CID) - Global Clinical Trials Review, 2025 - Product Thumbnail Image

Chemotherapy-Induced Diarrhea (CID) - Global Clinical Trials Review, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Crohn's Disease (Regional Enteritis) - Global Clinical Trials Review, 2024 - Product Thumbnail Image

Crohn's Disease (Regional Enteritis) - Global Clinical Trials Review, 2024

  • Clinical Trials
  • December 2024
  • 1389 Pages
  • Global
From
Loading Indicator

The Gastrointestinal Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs used to treat diseases and disorders of the gastrointestinal tract. These drugs are used to treat conditions such as irritable bowel syndrome, Crohn's disease, ulcerative colitis, and gastroesophageal reflux disease. Commonly prescribed drugs include antacids, proton pump inhibitors, and H2 receptor antagonists. The Gastrointestinal Drugs market is highly competitive, with many large pharmaceutical companies vying for market share. Some of the major players in the market include Pfizer, GlaxoSmithKline, Merck & Co., AstraZeneca, and Novartis. These companies are constantly developing new drugs and treatments to meet the needs of patients. Show Less Read more